Trials / Completed
CompletedNCT00631358
Assessment of Inflammatory Biomarkers Expressed in a Sjogren's Population: Effect of a Topical Steroid Intervention
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 97 (actual)
- Sponsor
- Alcon Research · Industry
- Sex
- All
- Age
- 17 Years
- Healthy volunteers
- Accepted
Summary
The primary purpose of this study is to quantify the change in expression of biomarkers on the ocular surface of Sjogren's Syndrome participants after treatment with Maxidex.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Maxidex | Maxidex (0.1% Dexamethasone) 1 drop in each eye 2 times daily |
| OTHER | No treatment | Healthy normal control group receiving no treatment |
Timeline
- Start date
- 2008-02-01
- Primary completion
- 2009-02-01
- First posted
- 2008-03-07
- Last updated
- 2010-04-12
- Results posted
- 2010-04-12
Locations
2 sites across 1 country: Canada
Source: ClinicalTrials.gov record NCT00631358. Inclusion in this directory is not an endorsement.